Preferred Label : Anti-spike Protein SARS-CoV-2 Monoclonal Antibody;

NCIt synonyms : Anti-SARS-CoV-2 S Protein Monoclonal Antibody; Anti-SARS-CoV-2 Spike Protein Monoclonal Antibody; Anti-SARS-CoV-2 Coronavirus Spike Protein Monoclonal Antibody;

NCIt related terms : Monoclonal antibodies against SARS-CoV-2;

NCIt definition : Any monoclonal antibody that is directed against the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).;

Alternative definition : ACC/AHA: Any monoclonal antibody that is directed against the spike (S) protein of SARS-CoV-2;

NCI Metathesaurus CUI : CL1407554;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/kavigale
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
Sipavibart
drug approval
europe
Sipavibart
sipavibart
adolescent
adult
immunocompromised host
COVID-19
infusions, intravenous
injections, intramuscular
Anti-spike Protein SARS-CoV-2 Monoclonal Antibody
antibodies, monoclonal
antibodies, monoclonal
product surveillance, postmarketing
Pre-Exposure Prophylaxis

---
https://www.cochrane.org/fr/CD014945/HAEMATOL_les-anticorps-monoclonaux-specifiques-de-la-covid-19-fabriques-en-laboratoire-sont-ils-efficaces
2022
false
false
false
United Kingdom
COVID-19
cilgavimab and tixagevimab drug combination
casirivimab and imdevimab drug combination
bamlanivimab
Anti-spike Protein SARS-CoV-2 Monoclonal Antibody
review of literature
french abstract
antibodies, monoclonal

---
https://www.ansm.sante.fr/actualites/anticorps-monoclonaux-lansm-permet-lutilisation-en-acces-precoce-de-deux-bitherapies-contre-la-covid-19
2021
false
false
false
France
French
scientific and technical information
drug information
antibodies, monoclonal
adult
Casirivimab/Imdevimab
Casirivimab
Imdevimab
Anti-spike Protein SARS-CoV-2 Monoclonal Antibody
Bamlanivimab
Etesevimab
aged
spike glycoprotein, coronavirus
france
drug monitoring
risk
drug combinations
casirivimab and imdevimab drug combination
COVID-19
COVID-19
casirivimab
imdevimab
casirivimab and imdevimab
drug combinations
antibodies, monoclonal, humanized
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal product form)
casirivimab and imdevimab drug combination

---
Nous contacter.
07/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.